BELLUS Health Inc.

(BLU:CA)

By |

Profile

BELLUS Health Inc is a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough.

Contact Information

Website: www.bellushealth.com
Email: ir@bellushealth.com
Main Phone: +1 450 680-4500
Address: 275 Armand-Frappier Boulevard
State: QC
City / Town: Laval
Country: CAN
Postal Code: H7V 4A7

Issuer Information

Exchange: TSX
CEO: Roberto Bellini
Employees: 8
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

BELLUS Health Inc is a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough.

Contact Information

Website: www.bellushealth.com
Email: ir@bellushealth.com
Main Phone: +1 450 680-4500
Address: 275 Armand-Frappier Boulevard
State: QC
City / Town: Laval
Country: CAN
Postal Code: H7V 4A7

Issuer Information

Exchange: TSX
CEO: Roberto Bellini
Employees: 8
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 1.03 $ -0.04 (-3.74%)
Last Price 1.03 Change $ -0.04 Change % -3.74 Tick N/A
Bid 1.03 Bid Size 7,100.00 Ask 1.07 Ask Size 13,900.00
Open 1.05 High 1.07 Low 1.03 Prev Close 1.07
Last Trade Volume 35,150 52 Wk Hi 1.30 52 Wk Low 0.33
Market Cap 161.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 157,039,686.00 EPS (TTM) -0.09 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1 1 1 1
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 1 1 1 1
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.3 2.3 2.3 2.3